Dublin, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The "Global In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.
The Global In Silico Clinical Trials Market is poised for substantial growth, with the market estimated at USD 2.71 billion in 2022 and projected to reach USD 6.46 billion by 2030. This market report provides comprehensive insights into this dynamic industry, offering crucial information to business leaders looking to navigate and succeed in the in silico clinical trials market.
Key Insights:
- Historical and Forecast Data: The report covers historical data from 2018 to 2021, with 2022 as the base year, and forecasts market trends and values up to 2030.
- Political and Economic Factors: The report considers the ongoing political and economic uncertainties resulting from the Russia-Ukraine Conflict and the impact of High Inflation on the global economy. It assesses how these factors may affect demand-supply balances, pricing, and trade in the in silico clinical trials market.
- Market Segmentation: The market is segmented based on Therapeutic Area (Infectious Diseases and Oncology), Phase (Phase I, Phase II, and Phase III), Industry (Medical Devices and Pharmaceutical), and Region (Americas, Asia-Pacific, and Europe, Middle East & Africa). Europe, Middle East & Africa is projected to witness significant market share growth during the forecast period.
Market Dynamics:
- Drivers: Factors driving market growth include the rising prevalence of chronic diseases worldwide, the need for efficient drugs, and increased R&D expenditure for drug development.
- Restraints: Low awareness about in silico trials in developing economies is a potential restraint to market growth.
- Opportunities: Opportunities lie in technological advancements in in silico clinical trials and the utilization of advanced computational modeling and simulation tools.
- Challenges: Challenges include issues related to protein flexibility, molecule conformation, and promiscuity.
Key Players:
The report identifies key companies in the in silico clinical trials market, including:
- Aganitha AI Inc.
- GNS Healthcare
- Insilico Medicine
- InSilicoTrials Technologies
- Instem Group of Companies
- Labcorp Drug Development
- Novadiscovery SAS
- Thornton Tomasetti
- ZMT Zurich MedTech AG
Competitive Landscape:
The report provides insights into the competitive landscape of the in silico clinical trials market, including market share analysis. This information helps businesses assess their market position compared to competitors and make informed decisions.
This comprehensive report is a valuable tool for decision-makers in the in silico clinical trials industry. It offers insights into market trends, segmentation, and competitive guidelines, allowing businesses to strategically position themselves for success in this rapidly growing market.
For more information about this report visit https://www.researchandmarkets.com/r/i9p07l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
